Bristol-Myers Squibb
BMY
BMY
2,287 hedge funds and large institutions have $96.1B invested in Bristol-Myers Squibb in 2021 Q3 according to their latest regulatory filings, with 109 funds opening new positions, 970 increasing their positions, 881 reducing their positions, and 151 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
11% less funds holding in top 10
Funds holding in top 10: 72 → 64 (-8)
11% less capital invested
Capital invested by funds: $108B → $96.1B (-$12.4B)
28% less first-time investments, than exits
New positions opened: 109 | Existing positions closed: 151
Holders
2,287
Holding in Top 10
64
Calls
$1.55B
Puts
$1.29B
Top Buyers
| 1 | +$342M | |
| 2 | +$282M | |
| 3 | +$246M | |
| 4 |
Barclays
London,
United Kingdom
|
+$139M |
| 5 |
JP Morgan Chase
New York
|
+$135M |
Top Sellers
| 1 | -$418M | |
| 2 | -$254M | |
| 3 | -$251M | |
| 4 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$182M |
| 5 |
KBC Group
Brussels,
Belgium
|
-$140M |